| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is making significant strides in product development, particularly in obesity treatments and weight management solutions, as reflected in its successful drug trials and innovative approaches. The anticipated launches and efficacy of new therapeutic options not only demonstrate Eli Lilly's commitment to addressing pressing health issues but also position it as a leader in the market. The growing focus on obesity treatments aligns with an increasing demand for effective weight-loss solutions, providing a strong foundation for future growth. However, the competitive landscape and potential regulatory hurdles could impact the pace of product development. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.9 is bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.9, and the negative at -0 on 2025-12-18. The forces of Sentiment towards Fundamentals (3), Stock Price Trend (0.9), Option Sentiment (0.8), Valuation Sentiment (0.7), Sector Price Trend (0.1), and Price Level Sentiment (0) will drive up the price. The forces of and Market Risk Appetite (-0.2) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | 0%(0%) | 1056.65 | 61 | 1.44% | 0.42% | 0.9 | 0.05% | 0.8% | 0.9 | Long | 65% | 3 | 6.5 |
| 2025-12-17 | 0%(0%) | 1041.61 | 50 | -1.19% | 0.08% | 0.9 | -0.08% | 0.6% | 0.9 | Wait | 50% | 3 | 0 |
| 2025-12-16 | 0%(0%) | 1054.13 | 60 | -0.81% | 0.09% | 1.1 | 0.2% | 1.4% | 1.2 | Long | 65% | 4 | -1 |
| 2025-12-15 | 0%(0%) | 1062.71 | 67 | 3.37% | 0.05% | 1.1 | 0.29% | 1.9% | 1.3 | Long | 65% | 4.2 | 6.3 |
| 2025-12-14 | 0%(0%) | 0.6 | 0.24% | 0.8 | 4 | -1 | |||||||
| 2025-12-13 | 0%(0%) | 0.6 | 0.24% | 0.9 | 4.3 | -1 | |||||||
| 2025-12-12 | 0%(0%) | 1028.09 | 43 | 1.88% | -0.44% | 0.6 | 0.24% | 1.3% | 1.3 | Long | 65% | 4.3 | -1 |
| 2025-12-11 | 0%(0%) | 1009.14 | 29 | 1.63% | -0.92% | -0.6 | 0.05% | 1.3% | 0.8 | Wait | 50% | 3.6 | 7 |
| 2025-12-10 | 0%(0%) | 992.94 | 16 | 1.15% | -1.12% | -0.5 | 0.02% | 0.6% | 0.9 | Wait | 50% | 3.1 | 7 |
| 2025-12-09 | 0%(0%) | 981.67 | 8 | -1.59% | -0.82% | -0.7 | -0.15% | 0.9% | 1 | Wait | 50% | 2.7 | 6 |
| Long is the preferred trading strategy with 65% chance of being right. The trend sentiment plus market sentiment (moving force) is positive, and market sentiment change is positive. The price level is not too high. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-12-18 17:02:06 The emergence of various treatment options for obesity indicates an increasingly competitive environment among pharmaceutical companies aiming to dominate this market. |
| 2025-12-18 17:02:06 The articles reveal a broader industry trend as confidence in pharmaceutical companies like Eli Lilly grows due to advancements in treatments for obesity. |
| 2025-12-18 17:02:06 The articles reflect positively on the stock performance of Eli Lilly, especially after successful trials and studies related to its weight-loss products. |
| 2025-12-18 17:02:06 The development and success of Eli Lilly's new weight-loss pill indicate a strong trend in product innovation and addressing obesity through pharmaceutical solutions. |
| 2025-12-18 17:02:06 Several articles discuss increased investment activities surrounding Eli Lilly, highlighting a growing confidence in the company's stock performance and future growth. |
| 2025-12-18 13:48:25 There is a growing interest in sustainable treatments for long-term weight management among obesity patients. |
| 2025-12-18 13:48:25 The effectiveness of Eli Lilly's orforglipron as a maintenance therapy for weight loss is highlighted. |
| 2025-12-18 09:34:41 The implications of seeking FDA approval reflect regulatory challenges and opportunities for new pharmaceuticals in the obesity market. |
| 2025-12-18 09:34:41 The development and approval of new obesity treatments, specifically Eli Lilly's orforglipron, represents significant advancements in healthcare. |